The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDalata Hotel Gp Regulatory News (DAL)

Share Price Information for Dalata Hotel Gp (DAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 358.00
Bid: 330.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 56.00 (16.97%)
Open: 358.00
High: 0.00
Low: 0.00
Prev. Close: 358.00
DAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dalata Hotel Group PLC: Trading Update

14 Jun 2023 07:00

Dalata Hotel Group PLC (DAL,DHG) Dalata Hotel Group PLC: Trading Update 14-Jun-2023 / 07:00 GMT/BST


Trading Update

ISE: DHG              LSE: DAL

Dublin and London | 14 June 2023:  Dalata Hotel Group Plc (“Dalata” or “the Group”), the largest hotel operator in Ireland, with a growing presence in the United Kingdom and continental Europe, provides a trading update for the second quarter of 2023.

The Group has continued to trade strongly and expects Adjusted EBITDA to be in excess of €100 million for the six months ending 30th June 2023. This reflects a very strong first half trading performance across the Group’s existing hotels and the continued impact of new hotels as they ramp up. Dalata disclosed in April that Group ‘like for like’ RevPAR[i] was 28% ahead of 2019 levels for the January to April period. RevPARi is expected to be 29% ahead of 2019 levels for the H1 period.

The Group’s margin performance has continued to improve, and Dalata’s decentralised hotel teams are successfully managing the inflationary environment through the use of dynamic pricing, cost management and an increase in sustainability initiatives delivering a reduction in utility consumption. The Group continues to utilise innovation to drive efficiencies whilst protecting or enhancing both our employee and customer experience, this has been highly successful during the period.

Dalata looks forward with confidence to the summer trading period as demand is robust across all markets. We continue to see a strong mix of corporate and leisure business boosted by the return of international travel and sustained domestic demand.

‘Like for like’ Group RevPARi ahead of 2022 levels:

Q2 2023

Dublin

+10%

Regional Ireland

+15%

UK

+15%

Group

+11%

The Group continues to execute on its UK growth strategy with two new London hotel acquisitions, demonstrating its ability to reinvest Free Cashflow and expand its hotel portfolio. Maldron Hotel Finsbury Park and Clayton Hotel London Wall are due to commence operations for the Group in the coming weeks. Development works on Dalata’s other pipeline hotels are progressing well, with Maldron hotels in Shoreditch London, Brighton, Liverpool and Manchester on track to open in 2024. These additions will further enhance the Group’s portfolio of modern four-star hotels as it continues to deliver on its strategic growth plan.

Dermot Crowley, CEO, Dalata said:

“I am delighted with our performance for the year to date. The financial performance is the result of the dedication and professionalism of our teams in our hotels and central office – our people remain our greatest strength. I am very pleased with the performance of the hotels we recently added to the portfolio, it gives me great confidence that the current pipeline of new hotels will also create significant value for our shareholders. We continue to deliver on our growth strategy with the exciting addition of two new hotels in London since the start of the year. The excellence of our people, the ongoing strength of demand across our markets and the quality of our portfolio gives me great confidence for the remainder of the year.”

-ENDS-

 

About Dalata

Dalata Hotel Group plc was founded in August 2007 and listed as a plc in March 2014. Dalata is Ireland’s largest hotel operator, with a growing presence in the UK and continental Europe. The Group’s portfolio comprises 50 three and four-star hotels with 10,953 rooms and a pipeline of over 1,400 rooms. The Group currently has 29 owned hotels, 18 leased hotels and three management contracts. Dalata successfully operates Ireland’s two largest hotel brands, the Clayton and the Maldron Hotels. For the year ended 31 December 2022, Dalata reported revenue of €558.3 million and a profit after tax of €96.7 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL). For further information visit: www.dalatahotelgroup.com

 

 

Contacts

Dalata Hotel Group plc

Tel +353 1 206 9400

Dermot Crowley, CEO

investorrelations@dalatahotelgroup.com

Shane Casserly, Corporate Development Director

Carol Phelan, CFO

 Graham White, Head of Investor Relations

 

Joint Company Brokers

 

Davy: Anthony Farrell

Tel +353 1 679 6363

Berenberg: Ben Wright

Tel +44 20 3753 3069

 

 

Investor Relations and PR | FTI Consulting

Tel +353 86 401 5250

Melanie Farrell

dalata@fticonsulting.com

 

 

 

 

 

 

 

 

 

 


i RevPAR is stated on a ‘like for like’ basis and excludes the performance of hotels that newly opened or ceased trading under Dalata during the comparative years. For newly acquired, previously operating hotels, where pre-acquisition RevPAR data is available, these hotels are included on a ‘like for like’ basis.


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:IE00BJMZDW83, IE00BJMZDW83
Category Code:TST
TIDM:DAL,DHG
LEI Code:635400L2CWET7ONOBJ04
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:250641
EQS News ID:1656283
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
20th Dec 201812:00 pmRNSHolding(s) in Company
18th Dec 20187:00 amRNSTrading Update
12th Dec 20183:33 pmRNSHolding(s) in Company
3rd Dec 20188:57 amRNSTotal Voting Rights
30th Nov 20184:53 pmRNSDirector/PDMR Shareholding
30th Nov 20182:22 pmRNSHolding(s) in Company
23rd Nov 20182:12 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:11 pmRNSDirector/PDMR Shareholding
23rd Nov 20182:10 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:27 pmRNSHolding(s) in Company
16th Nov 20184:51 pmRNSAcquisition
12th Nov 201811:57 amRNSHolding(s) in Company
8th Nov 20187:00 amRNSStatement re Block Listing Application
5th Nov 20184:15 pmRNSStatement re Refinancing
30th Oct 20188:58 amRNSHolding(s) in Company
1st Oct 20183:00 pmRNSTotal Voting Rights
28th Sep 20184:35 pmRNSHolding(s) in Company
20th Sep 201810:10 amRNSDirector/PDMR Shareholding
17th Sep 201810:02 amRNSConversion Rate for 2018 Interim Dividend
7th Sep 20189:22 amRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSDirector/PDMR Shareholding
4th Sep 20187:00 amRNSHalf-year Report
3rd Sep 20182:41 pmRNSTotal Voting Rights
30th Aug 201812:50 pmRNSHolding(s) in Company
29th Aug 20187:00 amRNSAcquisition of London Hotel
1st Aug 20189:13 amRNSTotal Voting Rights
25th Jul 201812:09 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSNotice of Results
23rd Jul 20182:39 pmRNSHolding(s) in Company
2nd Jul 201810:20 amRNSTotal Voting Rights
6th Jun 20183:55 pmRNSTotal Voting Rights
6th Jun 20187:00 amRNSMain Securities Market Notice
5th Jun 20187:00 amRNSBlocklisting Application
16th May 20187:00 amRNSAnnounces Two New Hotels in Bristol & Birmingham
3rd May 20184:18 pmRNSResult of AGM
3rd May 20187:00 amRNSAGM Statement
1st May 20188:27 amRNSTotal Voting Rights
11th Apr 20183:20 pmRNSDirector/PDMR Shareholding
10th Apr 20188:12 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSMain Securities Market Notice
9th Apr 20182:00 pmRNSBlock Listing Application
3rd Apr 20184:35 pmRNSPrice Monitoring Extension
3rd Apr 20189:14 amRNSTotal Voting Rights
29th Mar 20185:00 pmRNSAnnual Financial Report
21st Mar 20183:59 pmRNSDirector/PDMR Shareholding
20th Mar 20183:55 pmRNSHolding(s) in Company
12th Mar 20183:51 pmRNSDirector/PDMR Shareholding
1st Mar 20181:34 pmRNSTotal Voting Rights
27th Feb 20187:00 amRNSFinal Results
12th Feb 20187:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.